Key result
A wide range of therapeutic options, including lifestyle changes, pharmacological agents, revascularization, and emerging biological therapies, are available or in development for chronic myocardial ischemia.
This review highlights the wide range of current therapies for chronic myocardial ischemia and the ongoing development of novel approaches like therapeutic angiogenesis to address residual symptoms.
No takes yet. Share an insight, caveat, or question.
Supports multimodal therapy selection in chronic myocardial ischemia; leaves open comparative efficacy of emerging biological approaches.
Patrick W. Serruys (2004) conducted a review in Chronic myocardial ischaemia. Therapeutic options (lifestyle, pharmacological, surgical, and emerging biological therapies) was evaluated. A wide range of therapeutic options, including lifestyle changes, pharmacological agents, revascularization, and emerging biological therapies, are available or in development for chronic myocardial ischemia.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: